Skip to main content
Premium Trial:

Request an Annual Quote

GeneOhm Completes $14M Second Closing of Series C; Round Now Totals $26M

NEW YORK, Jan. 18 (GenomeWeb News) - GeneOhm Sciences has raised $14 million in a second closing of a Series C venture capital financing round.


The San Diego-based firm, which develops tools for molecular diagnostic applications, completed a $12 million first closing of the Series C late last year when it merged with Infectio Diagnostic.


New investors Kaiser Permanente Ventures, QuestMark Partners, and Posco Bioventures participated in the financing round along with existing investors Domain Associates, SGF Sante, CHL Medical Partners, CB Health Ventures, and CDIB.


GeneOhm said the funds would be used to accelerate commercialization of its molecular diagnostics technology for infectious disease pathogens, genetic mutations linked to inherited diseases, and oncology.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.